| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |